Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
28,57 USD | +12,08% | +12,84% | +3,66% |
21:58 | Sectorupdate: Gezondheidszorgaandelen randen hoger aan het eind van de middag | MT |
21:32 | Sectorupdate: Gezondheidszorg | MT |
Vakgebied
Aantal werknemers: 1 022
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small Molecule and Gene Therapeutics
100,0
%
| 699 | 100,0 % | 938 | 100,0 % | +34,20% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
56,7
%
| 499 | 71,3 % | 532 | 56,7 % | +6,64% |
Non-United States
43,3
%
| 200 | 28,7 % | 406 | 43,3 % | +102,84% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 01-10-19 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 13-07-23 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Neil Almstead
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-00 |
Kylie O'Keefe
IRC | Investor Relations Contact | - | 01-05-18 |
Human Resources Officer | - | 01-01-18 | |
Timothy Dyer
SEC | Corporate Secretary | - | 01-06-18 |
Marla Weetall
PRN | Corporate Officer/Principal | - | 01-10-02 |
Corporate Officer/Principal | - | - | |
Christine Utter
AUD | Comptroller/Controller/Auditor | 46 | 01-01-10 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15-06-15 |
Chairman | 72 | 01-08-01 | |
David Southwell
BRD | Director/Board Member | 63 | 01-12-05 |
Allan Jacobson
FOU | Founder | 78 | 31-03-98 |
Emma Reeve
BRD | Director/Board Member | 63 | 18-12-18 |
Jerome Zeldis
BRD | Director/Board Member | 74 | 28-09-12 |
Alethia Young
BRD | Director/Board Member | 45 | 09-06-22 |
Matthew Klein
CEO | Chief Executive Officer | 52 | 01-10-19 |
Mary Smith
BRD | Director/Board Member | 61 | 08-06-21 |
Stephanie Okey
BRD | Director/Board Member | 64 | 18-12-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 76 608 030 | 74 476 987 ( 97,22 %) | 0 | 97,22 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
CLEARPOINT NEURO, INC. 3.32% | 894 578 | 3.32% | 6 083 130 $ |
Bedrijfsgegevens
PTC Therapeutics, Inc.
100 Corporate Court
07080-2449, South Plainfield
+908 222 7000
http://www.ptcbio.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
PTC Therapeutics International Ltd.
|
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,66% | 1,95 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |
- Beurs
- Aandelen
- Koers PTCT
- Onderneming PTC Therapeutics, Inc.